Statistics
Publications
1
Citations
19
H-Index
1
Active since
2022
Affiliations
Io Therapeutics (United States)(Current)
Ricardo Ramirez is an author at Io Therapeutics (United States) specializing in cancer cell signaling, proteasome-mediated degradation, and basic leucine zipper transcription factors.
Publications per year
2022–2022
1
1
Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β
Emad Darvishi, Lila Ghamsari, Siok Leong et al. · Molecular Cancer Therapeutics · 2022 · 19 citations · Full text
Medicine, Cancer Biology, Oncology +15
1–1 of 1